Jeffrey D. McBride

1.3k total citations
51 papers, 1000 citations indexed

About

Jeffrey D. McBride is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Jeffrey D. McBride has authored 51 papers receiving a total of 1000 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Genetics. Recurrent topics in Jeffrey D. McBride's work include Biochemical and Structural Characterization (13 papers), Chemical Synthesis and Analysis (9 papers) and Peptidase Inhibition and Analysis (7 papers). Jeffrey D. McBride is often cited by papers focused on Biochemical and Structural Characterization (13 papers), Chemical Synthesis and Analysis (9 papers) and Peptidase Inhibition and Analysis (7 papers). Jeffrey D. McBride collaborates with scholars based in United States, United Kingdom and Australia. Jeffrey D. McBride's co-authors include Robin J. Leatherbarrow, Evangelos V. Badiavas, Luis Rodriguez-Menocal, Marta García-Contreras, Jian‐xing Ma, Matthew A. Cooper, Agnès M. Jaulent, Gonzalo J. Domingo, Bin Zhang and Alicia J. Jenkins and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Molecular Biology and Diabetes.

In The Last Decade

Jeffrey D. McBride

47 papers receiving 981 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey D. McBride United States 18 733 131 121 94 91 51 1000
Jen‐Chieh Tseng United States 18 1.0k 1.4× 108 0.8× 51 0.4× 184 2.0× 425 4.7× 35 1.6k
Edward M. Alderman United States 7 1.0k 1.4× 256 2.0× 60 0.5× 190 2.0× 141 1.5× 11 1.4k
Enrico Iaccino Italy 22 734 1.0× 332 2.5× 73 0.6× 150 1.6× 125 1.4× 48 1.1k
Sujeong Kim South Korea 19 796 1.1× 76 0.6× 75 0.6× 170 1.8× 212 2.3× 62 1.3k
Guang‐Hui Jin China 21 817 1.1× 190 1.5× 27 0.2× 219 2.3× 229 2.5× 46 1.3k
Cheng‐Chun Huang United States 18 400 0.5× 100 0.8× 95 0.8× 105 1.1× 197 2.2× 44 1.0k
Marta Kapałczyńska Poland 6 449 0.6× 156 1.2× 55 0.5× 125 1.3× 469 5.2× 8 1.4k
Daniela Hoeller Germany 17 1.4k 1.9× 169 1.3× 59 0.5× 188 2.0× 458 5.0× 24 1.8k
James Pan United States 18 781 1.1× 193 1.5× 81 0.7× 198 2.1× 284 3.1× 35 1.3k
Kang Choi South Korea 16 691 0.9× 110 0.8× 31 0.3× 97 1.0× 82 0.9× 27 1.1k

Countries citing papers authored by Jeffrey D. McBride

Since Specialization
Citations

This map shows the geographic impact of Jeffrey D. McBride's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey D. McBride with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey D. McBride more than expected).

Fields of papers citing papers by Jeffrey D. McBride

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey D. McBride. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey D. McBride. The network helps show where Jeffrey D. McBride may publish in the future.

Co-authorship network of co-authors of Jeffrey D. McBride

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey D. McBride. A scholar is included among the top collaborators of Jeffrey D. McBride based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey D. McBride. Jeffrey D. McBride is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McBride, Jeffrey D., et al.. (2026). Semaglutide-Induced Atypical Pustular Drug Eruption: A Case Report. Cureus. 18(1). e101016–e101016.
2.
Janknecht, Ralf, et al.. (2024). The Influence of Melanoma Extracellular Vesicles on Benign Melanocytes: A Role for PRAME in Modulation of the Tumor Microenvironment. Journal of Investigative Dermatology. 145(7). 1717–1727.e2.
3.
Hirshburg, Jason M., et al.. (2024). An unusual case of acquired generalized lipodystrophy (panniculitis variety). Pediatric Dermatology. 41(6). 1152–1155. 1 indexed citations
4.
Liu, Xiaochen, et al.. (2024). The Utilization of PRAME in the Diagnosis, Prognosis, and Treatment of Melanoma. Cells. 13(20). 1740–1740. 3 indexed citations
5.
Johnson, Jessica A., Amy S. Nowacki, Jeffrey D. McBride, et al.. (2023). Abnormal thrombosis and neutrophil activation increase hospital-acquired sacral pressure injuries and morbidity in COVID-19 patients. Frontiers in Immunology. 14. 1031336–1031336.
6.
Schulman, Carl I., Nicholas Namias, Louis R. Pizano, et al.. (2022). The effect of mesenchymal stem cells improves the healing of burn wounds: a phase 1 dose-escalation clinical trial. SHILAP Revista de lepidopterología. 8. 2817539391–2817539391. 19 indexed citations
7.
McBride, Jeffrey D., Melissa Piliang, Wilma F. Bergfeld, et al.. (2021). Preferentially expressed antigen in melanoma and p16 expression in acral melanocytic neoplasms. Journal of Cutaneous Pathology. 49(3). 220–230. 28 indexed citations
8.
McBride, Jeffrey D., Luis Rodriguez-Menocal, Aisha Khan, et al.. (2021). Proteomic analysis of bone marrow-derived mesenchymal stem cell extracellular vesicles from healthy donors: implications for proliferation, angiogenesis, Wnt signaling, and the basement membrane. Stem Cell Research & Therapy. 12(1). 328–328. 19 indexed citations
9.
Galimberti, Fabrizio, Jeffrey D. McBride, Yumeng Li, et al.. (2020). Evidence-based best practice advice for patients treated with systemic immunosuppressants in relation to COVID-19. Clinics in Dermatology. 38(6). 775–780. 12 indexed citations
11.
McBride, Jeffrey D., Xiaochen Liu, William L. Berry, et al.. (2017). Transgenic expression of a canonical Wnt inhibitor, kallistatin, is associated with decreased circulating CD19+ B lymphocytes in the peripheral blood. International Journal of Hematology. 105(6). 748–757. 6 indexed citations
12.
13.
McBride, Jeffrey D., Alicia J. Jenkins, Xiaochen Liu, et al.. (2014). Elevated Circulation Levels of an Antiangiogenic SERPIN in Patients with Diabetic Microvascular Complications Impair Wound Healing through Suppression of Wnt Signaling. Journal of Investigative Dermatology. 134(6). 1725–1734. 56 indexed citations
14.
Lee, Kyungwon, Rui Cheng, Kyoungmin Park, et al.. (2014). Receptor heterodimerization as a novel mechanism for regulation of Wnt/β-catenin signaling. Journal of Cell Science. 127(Pt 22). 4857–69. 24 indexed citations
15.
McBride, Jeffrey D., Alicia J. Jenkins, & Jian‐xing Ma. (2010). Increased Serum Kallistatin Levels in Patients With Type 1 Diabetes and Its Vascular Complications. Investigative Ophthalmology & Visual Science. 51(13). 5051–5051. 1 indexed citations
16.
McBride, Jeffrey D., et al.. (2003). The Structural Basis of a Conserved P2 Threonine in Canonical Serine Proteinase Inhibitors. Journal of Biomolecular Structure and Dynamics. 20(5). 645–655. 9 indexed citations
17.
Scarpi, Dina, Jeffrey D. McBride, & Robin J. Leatherbarrow. (2002). Inhibition of human β‐tryptase by Bowman–Birk inhibitor derived peptides. Journal of Peptide Research. 59(2). 90–93. 8 indexed citations
18.
McBride, Jeffrey D., et al.. (2001). Synthetic Peptide Mimics of the Bowman-Birk Inhibitor Protein. Current Medicinal Chemistry. 8(8). 909–917. 43 indexed citations
19.
McBride, Jeffrey D., et al.. (1999). The role of the P2′ position of Bowman-Birk proteinase inhibitor in the inhibition of trypsin. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1431(1). 232–237. 38 indexed citations
20.
McBride, Jeffrey D., et al.. (1996). Selection of Chymotrypsin Inhibitors from a Conformationally-constrained Combinatorial Peptide Library. Journal of Molecular Biology. 259(4). 819–827. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026